Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram in Moderate COVID-19
NCT04594343Phase 2Completed
- Sponsor
- Etica
- Start
- Nov 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of disulfiram in coronavirus disease 2019 (COVID-19), sponsored by Etica. Started Nov 2020; status: completed.
02
Drugs
disulfiram
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04594343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04594343.